[Home ] [Archive]    
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
Contact us::
Site Facilities::
Webmail::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 18, Issue 6 (January & February 2014 2014) ::
pajoohande 2014, 18(6): 287-295 Back to browse issues page
Effect of dietary supplementation with conjugated linoleic acid on bone mineral density, bone metabolism markers and inflammatory markers in healthy post-menopausal women: a randomized double blind placebo controlled trial
Azadeh Tavakoli Darestani , Reza Tavakoli Darestani * , Farideh Tahbaz , Farhad Hosseinpanah , Farideh Najafi
Associate Professor, Department of Orthopedics, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran , tavakolireza@mihanmail.ir
Abstract:   (7154 Views)
Background and Aim: Conjugated linoleic acid (CLA) has been shown to positively influence calcium and bone metabolism in experimental animals and cell culture, but there are limited human data available. Materials and Methods: The study consisted of a double-blind, placebo-controlled trial in which 76 healthy post-menopausal women (aged 55.1) were randomly assigned to receive daily either four capsules of CLA G80 containing 3.2 g isomer blend (50:50% cis-9, trans-11:trans-10, cis-12 isomers) or four capsules containing high oleic sunflower oil as placebo for 12 weeks. Urine and blood samples were collected at weeks 0 and 12 and were analyzed for biomarkers of calcium and bone metabolism and inflammatory markers (TNF-α and IL-6). Subjects completed 3-day dietary records during the trial in weeks 0 (baseline), 6, and 12. Results: Supplementation with 3.2 g CLA isomer blend (50:50% cis-9, trans-11:trans-10, cis-12 isomers) for 12 weeks had no significant effects on markers of bone formation (serum osteocalcin, bone-specific alkaline phosphatase) or bone resorption (urine C-telopeptide-related fraction of type 1 collagen degradation products), PTH, urinary calcium, urinary creatinine and CTP to creatinine ratio. Serum interlukine-6 did not change significantly over 12 weeks in postmenopausal women. ‍Conclusion: Under the conditions tested in this double-blind, placebo-controlled trial in postmenopausal women, 3.2 g CLA isomer blend (50:50% cis-9, trans-11:trans-10, cis-12 isomers) did not affect markers of bone metabolism and calcium.
Keywords: Conjugated linoleic acid (CLA), Post-menopausal women, Bone mineral density, IL-6
Full-Text [PDF 493 kb]   (3056 Downloads)    
Type of Study: Original | Subject: Medicine
Received: 2017 | Accepted: 2017 | Published: 2017
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Azadeh Tavakoli Darestani, Reza Tavakoli Darestani, Farideh Tahbaz, Farhad Hosseinpanah, Farideh Najafi. Effect of dietary supplementation with conjugated linoleic acid on bone mineral density, bone metabolism markers and inflammatory markers in healthy post-menopausal women: a randomized double blind placebo controlled trial. pajoohande 2014; 18 (6) :287-295
URL: http://pajoohande.sbmu.ac.ir/article-1-1642-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 18, Issue 6 (January & February 2014 2014) Back to browse issues page
Persian site map - English site map - Created in 0.06 seconds with 36 queries by YEKTAWEB 4645